stronger neominophagen c has been researched along with glycyrrhizic acid in 4 studies
Studies (stronger neominophagen c) | Trials (stronger neominophagen c) | Recent Studies (post-2010) (stronger neominophagen c) | Studies (glycyrrhizic acid) | Trials (glycyrrhizic acid) | Recent Studies (post-2010) (glycyrrhizic acid) |
---|---|---|---|---|---|
18 | 2 | 8 | 2,079 | 70 | 1,068 |
Protein | Taxonomy | stronger neominophagen c (IC50) | glycyrrhizic acid (IC50) |
---|---|---|---|
Corticosteroid 11-beta-dehydrogenase isozyme 1 | Homo sapiens (human) | 0.0115 | |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | Mus musculus (house mouse) | 0.0135 | |
Corticosteroid 11-beta-dehydrogenase isozyme 2 | Homo sapiens (human) | 0.0007 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishii, M; Miura, M; Miyazaki, Y; Takahashi, T; Toyota, T; Ueno, Y; Yamamoto, T | 1 |
Furutani, T; Gondo, T; Hidaka, I; Hino, K; Kawano, H; Korenaga, M; Nishina, S; Sakai, A; Sakaida, I; Shinozaki, A | 1 |
Rino, Y; Yamamoto, N; Yukawa, N | 1 |
Horikiri, T; Kaneko, Y; Kinoshita, A; Kurita, Y; Kuwano, K; Odashima, K; Saito, Z; Seki, A; Seki, Y; Takeda, H; Yoshii, Y | 1 |
1 review(s) available for stronger neominophagen c and glycyrrhizic acid
Article | Year |
---|---|
Does herbal medicine reduce the risk of hepatocellular carcinoma?
Topics: Animals; Anti-Inflammatory Agents; Benzimidazoles; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cysteine; Drug Combinations; Drugs, Chinese Herbal; Fatty Liver; Fluorenes; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Phytotherapy; Plant Preparations; Sofosbuvir; Tablets | 2015 |
3 other study(ies) available for stronger neominophagen c and glycyrrhizic acid
Article | Year |
---|---|
A case of drug-induced ductopenia resulting in fatal biliary cirrhosis.
Topics: Bile Duct Diseases; Bile Ducts, Intrahepatic; Cysteine; Drug Combinations; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Humans; Liver; Liver Cirrhosis, Biliary; Middle Aged; Rhinitis, Allergic, Seasonal | 1993 |
A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice.
Topics: Animals; Cysteine; DNA Primers; Dose-Response Relationship, Drug; Drug Combinations; Fatty Liver; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Immunoblotting; Iron; Iron, Dietary; Liver; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Electron, Transmission; Mitochondria; Oxidative Stress; Reactive Oxygen Species; Statistics, Nonparametric; Sterol Regulatory Element Binding Protein 1 | 2011 |
Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis.
Topics: Adult; Aged; Alanine Transaminase; Antitubercular Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cysteine; Drug Combinations; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Humans; Liver; Male; Middle Aged; Retrospective Studies; Risk Factors; Tuberculosis; Ursodeoxycholic Acid; Young Adult | 2016 |